Exenatide immediate-release (Byetta): Initiation involves a 5 mcg dose administered subcutaneously twice daily, which can be increased to 10 mcg twice daily after a month if required
When to consider GLP-1 microdosing Based on current clinical practice patterns, practitioners are most commonly recommending GLP-1 microdosing in these scenarios: Partial responders: Patients on standard therapy who have improved but still experience breakthrough flares, residual inflammation, or persistent symptoms
A multivitamin is not mandatory for every person on GLP-1, but for many women, it is one of the smartest and simplest ways to support nutrition while appetite is reduced
The six most-searched oral health symptoms associated with GLP-1 use tell the story clearly: Dry mouth / xerostomia Halitosis and bad breath Metallic taste in mouth Tooth sensitivity Every one of them is a direct downstream consequence of reduced saliva flow, and collectively they generated over 250,000 searches across the US in 2024
Mice were administered single s.c
have not been reviewed by the FDA for safety, effectiveness, or quality